Skip to main content
ENTA logo

ENTA

Enanta Pharmaceuticals, Inc.

$7.62

4.56%

Trade Ideas Performance

Latest Closed Trade Idea

$7.62

4.56%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

1

Social

62

About

Events of Enanta Pharmaceuticals, Inc. (ENTA)

Over the past six months, Enanta Pharmaceuticals' stock has been affected by several events. On October 29, 2026, a European Unified Patent Court ruled a related patent invalid and an infringement action unfounded. On October 28, 2026, CEO Jay R. Luly announced his retirement effective February 1, 2027. Clinical trial advancements include the initiation of dosing for zelicapavir in the RESOLVE Phase 2b/3 study for RSV in October 2026, and in the LOTUS Phase 2b pediatric trial in August 2026. The company also participated in several investor conferences. The stock experienced volatility, including a 9.6% decline over 30 days leading up to late October 2026, a -6.02% move on May 11, 2026, and traded at $11.00 on November 6, 2026, showing a 9.13% increase from the previous session, despite a 6.61% decrease in the past month and 15.72% over the past three months as of October 21, 2026.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)